<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">344017</id>
  <title nil="true"/>
  <common-name>5-[4-(4-cyanobut-1-ynyl)phenyl]-1-(2,4-dichlorophenyl)-4-(hydroxymethyl)-n-morpholin-4-ylpyrazole-3-carboxamide</common-name>
  <description>5-[4-(4-cyanobut-1-ynyl)phenyl]-1-(2,4-dichlorophenyl)-4-(hydroxymethyl)-n-morpholin-4-ylpyrazole-3-carboxamide is a chemical compound with the formula C26H23Cl2N5O3. With an average molecular weight of 524.40 g/mol, 5-[4-(4-cyanobut-1-ynyl)phenyl]-1-(2,4-dichlorophenyl)-4-(hydroxymethyl)-n-morpholin-4-ylpyrazole-3-carboxamide is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>46894021</pubchem-id>
  <chemical-formula>C26H23Cl2N5O3</chemical-formula>
  <weight>524.4</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T05:44:26Z</created-at>
  <updated-at type="dateTime">2026-08-31T05:44:26Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1COCCN1NC(=O)C2=NN(C(=C2CO)C3=CC=C(C=C3)C#CCCC#N)C4=C(C=C(C=C4)Cl)Cl</moldb-smiles>
  <moldb-formula>C26H23Cl2N5O3</moldb-formula>
  <moldb-inchi>InChI=1S/C26H23Cl2N5O3/c27-20-9-10-23(22(28)16-20)33-25(19-7-5-18(6-8-19)4-2-1-3-11-29)21(17-34)24(30-33)26(35)31-32-12-14-36-15-13-32/h5-10,16,34H,1,3,12-15,17H2,(H,31,35)</moldb-inchi>
  <moldb-inchikey>VQXIVPLXEIZJTH-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">523.117795</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>3.7</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM339910</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>5-[4-(4-cyanobut-1-ynyl)phenyl]-1-(2,4-dichlorophenyl)-4-(hydroxymethyl)-n-morpholin-4-ylpyrazole-3-carboxamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Pyrazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0294390</sync-id>
  <structure-inchikey>VQXIVPLXEIZJTH-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>800002000000000001000400000000000082000008000000000040000001000000010002002000000004000200000000000002200000081000000000400000000000000000000020800021000800000020000000000000040200090088000400000000100008800000020100120000000000010000000000000000000000400000000000080080800000000000400000000000000000000100000000000000000000088000040000000040000000008000000000000000000000000000000000000000000000000010000001000000200200000000004802000000000008000040000100001400000000280000000000000000002000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJwAAAIABBgBgAAAAAgIGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:43:20Z</structure-indexed-at>
</compound>
